Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
0.7827
+0.0056 (+0.72%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,238,024
Open
0.7846
Bid (Size)
0.7701 (168)
Ask (Size)
0.7890 (50)
Prev. Close
0.7771
Today's Range
0.7400 - 0.8000
52wk Range
0.6134 - 3.012
Shares Outstanding
348,875,959
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Agenus Reports Third Quarter 2023 Results
November 07, 2023
From
Agenus Inc.
Via
Business Wire
Agenus's Earnings Outlook
November 06, 2023
Via
Benzinga
Performance
YTD
-66.77%
-66.77%
1 Month
-5.77%
-5.77%
3 Month
-43.69%
-43.69%
6 Month
-51.08%
-51.08%
1 Year
-69.79%
-69.79%
More News
Read More
Agenus to Provide Third Quarter 2023 Financial Report and Corporate Update
October 26, 2023
From
Agenus Inc.
Via
Business Wire
Textainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session
October 23, 2023
Via
Benzinga
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
October 22, 2023
From
Agenus Inc.
Via
Business Wire
ESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma Subtypes
October 21, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Completes Enrollment in Randomized Phase 2 Clinical Trial of Botensilimab/Balstilimab in Advanced Colorectal Cancer
October 10, 2023
From
Agenus Inc.
Via
Business Wire
Agenus To Host BOT/BAL Program Update at ESMO 2023
October 05, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 01, 2023
From
Agenus Inc.
Via
Business Wire
HEICO, Canaan And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 29, 2023
Via
Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
August 28, 2023
Via
The Motley Fool
Agenus to Participate in September Investor Conferences
August 28, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers
August 23, 2023
From
Agenus Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
August 18, 2023
Via
Benzinga
SaponiQx Announces Breakthrough in Scaling Up of STIMULON™ Cultured Plant Cell Adjuvant
August 09, 2023
From
SaponiQx
Via
Business Wire
Agenus Reports Second Quarter 2023 Results
August 08, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Botensilimab/Balstilimab Data Update in Sarcomas Selected for Oral Presentation at ESMO 2023
July 28, 2023
From
Agenus Inc.
Via
Business Wire
Agenus to Provide Second Quarter 2023 Financial Report and Corporate Update
July 26, 2023
From
Agenus
Via
Business Wire
Agenus Expands Executive Leadership Team
July 20, 2023
From
Agenus Inc.
Via
Business Wire
ESMO GI Data: Agenus' Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced Colorectal Cancer
June 30, 2023
From
Agenus
Via
Business Wire
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
June 06, 2023
Via
Benzinga
Agenus Presents Positive Efficacy and Safety Outcomes for AGEN2373 at ASCO
June 05, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Announces Virtual Annual Shareholders Meeting
June 05, 2023
From
Agenus
Via
Business Wire
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.